330 related articles for article (PubMed ID: 3681370)
1. Tumor and liver drug uptake following hepatic artery and portal vein infusion.
Sigurdson ER; Ridge JA; Kemeny N; Daly JM
J Clin Oncol; 1987 Nov; 5(11):1836-40. PubMed ID: 3681370
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
Sigurdson ER; Ridge JA; Daly JM
Surgery; 1986 Aug; 100(2):285-91. PubMed ID: 2943036
[TBL] [Abstract][Full Text] [Related]
3. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein.
Ridge JA; Bading JR; Gelbard AS; Benua RS; Daly JM
Cancer; 1987 May; 59(9):1547-53. PubMed ID: 3828954
[TBL] [Abstract][Full Text] [Related]
4. Distribution of fluorodeoxyuridine uptake in the liver and colorectal hepatic metastases of human beings after arterial infusion.
Ridge JA; Sigurdson ER; Daly JM
Surg Gynecol Obstet; 1987 Apr; 164(4):319-23. PubMed ID: 2951882
[TBL] [Abstract][Full Text] [Related]
5. Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants.
Butler JA; Trezona TP; Nordestgaard A; State D
Am J Surg; 1989 Jan; 157(1):126-9. PubMed ID: 2521278
[TBL] [Abstract][Full Text] [Related]
6. Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake.
Thom AK; Sigurdson ER; Bitar M; Daly JM
Surgery; 1989 Mar; 105(3):383-92. PubMed ID: 2522247
[TBL] [Abstract][Full Text] [Related]
7. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
[TBL] [Abstract][Full Text] [Related]
8. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
Gerard A; Pector JC; Bleiberg H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
10. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein.
Daly JM; Kemeny N; Sigurdson E; Oderman P; Thom A
Arch Surg; 1987 Nov; 122(11):1273-7. PubMed ID: 2960296
[TBL] [Abstract][Full Text] [Related]
11. Bromodeoxyuridine uptake by early liver metastases in rats: a comparison of the hepatic artery and portal vein infusion routes.
Ishida H; Iwama T; Yoshinaga K; Gonda T; Idezuki Y
Surg Today; 1998; 28(8):822-9. PubMed ID: 9719004
[TBL] [Abstract][Full Text] [Related]
12. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
[TBL] [Abstract][Full Text] [Related]
13. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
14. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
Faynsod M; Wagman LD; Longmate J; Carroll M; Leong LA
J Clin Oncol; 2005 Aug; 23(22):4876-80. PubMed ID: 16009960
[TBL] [Abstract][Full Text] [Related]
15. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin alteration of drug uptake in an experimental model of hepatic metastases.
Trezona T; Butler JA; Vargas H
J Surg Res; 1991 Aug; 51(2):124-7. PubMed ID: 1830915
[TBL] [Abstract][Full Text] [Related]
17. Predicting tumor response in patients with colorectal hepatic metastases.
Daly JM; Butler J; Kemeny N; Yeh SD; Ridge JA; Botet J; Bading JR; DeCosse JJ; Benua RS
Ann Surg; 1985 Sep; 202(3):384-93. PubMed ID: 2931055
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
[TBL] [Abstract][Full Text] [Related]
19. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
20. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
